Remove Clinical Research Remove Clinical Trials Remove Life Science Remove Research
article thumbnail

How the New EU AI Act Will Impact Clinical Trials in the Life Sciences?

Cloudbyz

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation.

article thumbnail

Indian life sciences sector integrating technologies in R&D efforts

AuroBlog - Aurous Healthcare Clinical Trials blog

The Indian life sciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, big data, internet of things (IoT) and blockchain into their research and development efforts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Industry calls for boosting innovation and investment in NCEs and NBEs to propel life sciences growth

AuroBlog - Aurous Healthcare Clinical Trials blog

As the Union Budget approaches, the life sciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). The life sciences sector in India has shown remarkable resilience […]

article thumbnail

The Winning Formula For Life Sciences: Salesforce Life Sciences Cloud And Cloudbyz eClinical Solutions Collaboration

Cloudbyz

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

article thumbnail

Bridging Gaps in Rare Disease Clinical Trials: Insights from Collaborative Success in Pompe Disease Research

XTalks

Orphan drug development poses many challenges that are unique to rare diseases, including recruitment in small patient populations, variable progression with heterogenous clinical manifestations and limited understanding of disease progression and natural history.

article thumbnail

Can Prioritizing User Experience Reshape the Future of Clinical Research?

XTalks

As clinical trials become more complex, the need for user-centric design has never been more critical. His commitment to enhancing user experience is transforming how clinical trials are conducted, ensuring that both patients and site staff are supported throughout the process.

article thumbnail

Voices Matter: Integrating Patient Insights into Lupus Clinical Research

XTalks

These statistics underscore the urgent need for innovative treatments and inclusive clinical trials that can address the diverse needs of the lupus population. The complexity of lupus, combined with its significant impact on individuals and communities, makes it a critical area of focus for rheumatology research.